Physician profile
Bhupinder Singh
NPI 1649258138
$5,605.30
in general payments reported to CMS, 2019-2025
32 companies · $2,166 in 2025
The $2,166 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,047 · 2020: $386 · 2021: $541 · 2022: $393 · 2023: $460 · 2024: $612 · 2025: $2,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006 · Travel and Lodging: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.44 |
| Travel and Lodging | $1,231.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,550.44 | 2019-2025 | Esprit, Confirm Rx, Jot Dx |
| Boston Scientific Corporation | $528.18 | 2019-2025 | Varithena Administration Pack, Accolade Sr, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $443.55 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $298.92 | 2021-2024 | Verquvo |
| Amgen INC. | $296.95 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.65 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.38 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $124.43 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $111.22 | 2023-2025 | Camzyos |
| Abiomed | $95.91 | 2023-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $88.88 | 2020-2021 | |
| Shockwave Medical, INC | $85.50 | 2021 | |
| Ge Healthcare | $77.62 | 2019 | |
| Medtronic, INC. | $73.76 | 2022-2025 | Venaseal |
| Baxter Healthcare | $59.45 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cleerly, INC. | $53.94 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Edwards Lifesciences Corporation | $39.13 | 2019 | |
| Amarin Pharma, INC. | $38.20 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $37.89 | 2025 | Assure Wcd |
| Kerecis Limited | $34.66 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Glaxosmithkline, LLC. | $34.27 | 2025 | Arexvy |
| Janssen Pharmaceuticals, INC | $33.39 | 2019-2021 | |
| Novo Nordisk INC | $23.10 | 2024 | Ozempic |
| Siemens Medical Solutions USA, INC. | $23.00 | 2023 | Biograph Horizon-3r, Artis Q Floor |
| Astellas Pharma US INC | $18.21 | 2020 | |
| Angiodynamics, INC. | $17.57 | 2023 | Auryon Laser System 100-120 Vac |
| Acist Medical Systems, INC. | $16.81 | 2019 | |
| Gilead Sciences, INC. | $16.61 | 2019 | |
| Osprey Medical INC | $16.00 | 2019 | |
| Medtronic Vascular, INC. | $12.89 | 2020 | |
| Tactile Systems Technology INC | $11.56 | 2019 | |
| Esperion Therapeutics, INC. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhupinder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.